• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Flexible Sensors Detect Heavy Metals in Sweat

      Flexible Sensors Detect Heavy Metals in Sweat

      Nanopore Sensor to Study Protein Aggregation in Neurodegeneration

      Nanopore Sensor to Study Protein Aggregation in Neurodegeneration

      Biobots Use Optogenetic Muscle Actuators for Movement

      Biobots Use Optogenetic Muscle Actuators for Movement

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

    • Radiology
      Ultrasound Tornado Rapidly Disrupts Blood Clots

      Ultrasound Tornado Rapidly Disrupts Blood Clots

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Fluorescence Imaging System Illuminates Tumor Depth

      Fluorescence Imaging System Illuminates Tumor Depth

      Soft Robot Grows Like a Plant to Travel Through Tight Spaces

      Soft Robot Grows Like a Plant to Travel Through Tight Spaces

    • Cardiology
      Belt Monitors Heart Failure Patients

      Belt Monitors Heart Failure Patients

      Camera Measures Blood Pressure with Quick Look

      Camera Measures Blood Pressure with Quick Look

      Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

      Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

    • Surgery
      Microneedle Bandage for Hemostatic Control

      Microneedle Bandage for Hemostatic Control

      Biobots Use Optogenetic Muscle Actuators for Movement

      Biobots Use Optogenetic Muscle Actuators for Movement

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

    • Nanomedicine
      Extra Hot Nanoparticles for Cancer Therapy

      Extra Hot Nanoparticles for Cancer Therapy

      Making Tumors Tastier for the Immune System

      Making Tumors Tastier for the Immune System

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Magnetic Bacteria Target Tumors

      Magnetic Bacteria Target Tumors

    • Military Medicine
      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fabric Makes Electricity from Movement to Power Wearables

      Fabric Makes Electricity from Movement to Power Wearables

      Wearable Uses Microneedles to Track Metabolism

      Wearable Uses Microneedles to Track Metabolism

    • Rehab
      Smart Walking Stick for Visually Impaired People

      Smart Walking Stick for Visually Impaired People

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Implanted Magnets for Prosthetic Control

      Implanted Magnets for Prosthetic Control

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

The Next Decade of Neurostimulation: Interview with Simon Karger from Cambridge Consultants

September 24th, 2014 Medgadget Editors Exclusive, Medicine, Neurology, Neurosurgery, Rehab

Cambridge-ConsultantsCambridge Consultants recently held a neurostimulation workshop with leading innovators in the field. Following the workshop, the company released a working paper that looks at the potential of neurostimulation in the next ten years. Titled “Neurostimulation 2024” the report from the group believes that this promising new therapy has the ability to revolutionize patient care by delivering “immediate outcomes that relieve patients of debilitating pain, drugs and accompanying side effects.” We had a chance to speak with Simon Karger, who is a head of surgical and interventional products at Cambridge Consultants, about the report and what the future holds for neurostimulation.

Medgadget: In Neurostimulation 2024, the panel talks about the “new therapeutic ecosystem” for patients with lifestyle-conditions, such as obesity, depression, migraines, etc. Can you explain what this new ecosystem is, and how it is going to impact delivery of care for individual patients and health care as a whole?

Simon-KargerSimon Karger, Cambridge Consultants: The next generation of neurostimulation systems will comprise multiple components that allow therapy to be delivered at different ‘levels’ and to be tailored by patient and condition:

Level 1 – “In the patient”: a lightweight implanted device that will deliver the actual stimulation but contain minimal electronics or battery to minimize its size and the need for repeat surgery.

Level 2 – “On the patient”: an external patient / physician control unit that will provide an interface to the implanted system. While simple controllers exist today, our vision is that this system will provide for real-time communication with the implant, deliver power wirelessly, and allow for much more recording and processing of data than is practical on current implants. Potentially integrated into a common consumer platform (like a phone or tablet), this system will provide the ability to manage therapy in a highly contextualized way, responding to the needs of the patient in real-time and potentially even ‘closing the loop’.

Level 3 – “Near the patient”: an infrastructure of digital services that will link a patient, their condition and their therapy to key clinical stakeholders, caregivers and potentially even provide healthcare system-level data.

It is the combination of these networks, and their interaction through the ‘near the patient’ element that delivers the new therapeutic ecosystem. Real-time contextual control and feedback that’s linked to a network of digital services is going to be incredibly powerful, enhancing the ability of physicians and caregivers to track patient conditions, monitor their therapy (particularly for chronic conditions), and tweak their therapies accordingly. It’s worth noting that this ecosystem (along with implant size) is one of the key enablers of neurostimulation’s application to many new, chronic conditions. Episodic conditions like migraines are characterized by discreet ‘episodes,’ and therapy that can be invoked as needed and tailored to the needs of each episode and patient.

 

Medgadget: What role do you envision Cambridge Consultants will play in developing and implementing the necessary features of the future neurostimulation landscape?

Karger: Today’s neuromodulation implant manufacturers have appropriately focused their expertise in the challenges of the implant itself – waveforms, control systems and implantable power storage, for instance. However, this next generation of neurostimulation systems demand a much broader set of expertise: through-body wireless technology, specialized low power electronics, custom ASICs for implanted applications, novel power transmission modalities, context aware control systems, closed loop control, human factors and interface design, as well as digital service development. Cambridge Consultants packages these unique areas of expertise to work with companies looking to develop a next generation neurostimulation system.

 

Medgadget: Your report mentions that the neurostim industry is dominated by a few large players and many smaller ambitious startups working in “a highly fractured clinical landscape.” What do you think needs to be done to encourage these startups and increase collaboration between them?

Karger: The big players in the market need to establish their visions for the future and help the small companies align with those. Clinically, the industry needs to demonstrate the clinical value of these technologies and make clear where the financial value is likely to be. Ultimately, funding needs to be made available and clinical appetite enhanced to explore and implement this therapy for new applications.

 

Medgadget: Do you think that open source solutions that other industries employ can repair the fractured clinical landscape of neuroscience, and everyone from patients to companies will benefit?

Karger: Potentially. As a therapy relying on concentric rings of devices and services, there is great potential for an open source model. However, such systems can only thrive if standards for interfacing between sub-systems are clearly defined. That is always a challenge and is made even harder in the regulated world of medical devices.

 

Medgadget: How can we push big and small players to go open source?

Karger: Regulators must drive the creation of standards from the top-down, providing a framework for interoperation that is both safe and demonstrates the willingness of the clinical industry to adopt such a model. In doing so, they demonstrate where the dollars flow in the system in such a way that each component is viable.

 

Medgadget: Closing thoughts?

Karger: Neurostimulation is an incredibly exciting therapy that is at a tipping point. The technologies to deliver the vision are there, the clinical case is building and the potential for that vision to impact patients’ lives is clear. They key next step needs to be the alignment of technology expertise, clinical application, reimbursement models and regulatory structures. Everyone in the industry has a great opportunity to make this happen.

divider

Link: Neurostimulation 2024: workshop report (reg required)…

Cambridge Consultants homepage…

Medgadget Editors

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

Sponsored
C-mo Medical Solutions extends seed investment round to €4.8 million to transform cough monitoring

C-mo Medical Solutions extends seed investment round to €4.8 million to transform cough monitoring

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

Fluidx Unveils New Embolic for Neurovascular Use

Fluidx Unveils New Embolic for Neurovascular Use

Annalise.ai and Nuance Communications (a Microsoft Company) Announce Key Partnership to Improve Patient Outcomes with Workflow-Integrated AI

Annalise.ai and Nuance Communications (a Microsoft Company) Announce Key Partnership to Improve Patient Outcomes with Workflow-Integrated AI

PT Genie Unveils New Brand Identity Reflecting Company’s Transformation and Focus on the Global Future of AI and Machine Learning in Digital Healthcare

interviews & reviews
Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical

Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical

Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

In-Office Pediatric Ear Tube Procedures: Interview with Preceptis Medical's Greg Mielke

In-Office Pediatric Ear Tube Procedures: Interview with Preceptis Medical's Greg Mielke

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
Posting....
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email